| Curetis N.V.. (5/18/18). "Press Release: Curetis Publishes Business and Financial Update for the First Quarter 2018". Amsterdam, Holzgerlingen & San Diego, CA. |
2018-05-18 |
| Roche. (5/17/18). "Press Release: Phase III IMpower150 Study Showed Roche’s Tecentriq and Avastin plus Carboplatin and Paclitaxel Helped People with a Specific Type of Metastatic Lung Cancer Live Significantly Longer Compared to Avastin plus Carboplatin |
2018-05-17 |
| Roche. (5/17/18). "Press Release: Follow-up Phase III Data Showed Roche’s Alecensa Helped People with ALK-positive Metastatic Non-Small Cell Lung Cancer Live a Median of Almost Three Years Without Their Disease Worsening or Death". Basel. |
2018-05-17 |
| InflaRx N.V.. (5/17/18). "Press Release: InflaRx N.V. Reports First Quarter 2018 Financial & Operating Results". Jena. |
2018-05-17 |
| Idorsia Ltd.. (5/16/18). "Press Release: Idorsia Initiates MODIFY, a Phase 3 Registration Study to Assess Lucerastat as a Potential New Treatment Option for Patients with Fabry Disease". Allschwil. |
2018-05-16 |
| CellCentric Ltd.. (5/15/18). "Press Release: CellCentric Raises $26 Million to Take First-in-Class p300/CBP Inhibitor into the Clinic". |
2018-05-15 |
| Global Bioenergies S.A.. (5/15/18). "Press Release: Global Bioenergies Receives Three Additional Fundings from the European Union, further Supporting Its Strategy of Feedstock Diversification". Évry. |
2018-05-15 |
| Probiodrug AG. (5/15/18). "Press Release: Probiodrug AG Reports First Quarter 2018 Business Update". Halle (Saale). |
2018-05-15 |
| Aldevron LLC. (5/15/18). "Press Release: Aldevron Names Marc Wolff Chief Financial Officer". |
2018-05-15 |
| Calyxt, Inc.. (5/15/18). "Press Release: Bayer CropScience, LP Agrees to Settle Lawsuit Filed by Calyxt in Delaware Chancery Court". Minneapolis, MN. |
2018-05-15 |
| Medigene AG. (5/15/18). "Press Release: Medigene Reports Outcome of Annual General Meeting". Planegg. |
2018-05-15 |
| Merck KGaA. (5/15/18). "Press Release: Merck Reports a Solid Start to 2018". Darmstadt. |
2018-05-15 |
| CRISPR Therapeutics AG. (5/15/18). "Press Release: CRISPR Therapeutics Announces Presentations at the ASGCT 21st Annual Meeting". Zug & Cambridge, MA. |
2018-05-15 |
| Novartis AG. (5/15/18). "Press Release: Novartis Successfully Completes Acquisition of AveXis, Inc.". Basel. |
2018-05-15 |
| Acousia Therapeutics GmbH. (5/14/18). "Press Release: Acousia Therapeutics Announces €10 Million Series B Financing to Advance its Hearing Loss Portfolio". Tübingen. |
2018-05-14 |
| Valerius Biopharma AG. (5/14/18). "Press Release: Catalent Biologics and Valerius Biopharma to Collaborate on Manufacture of Specialty Biosimilars". Somerset, NJ & Basel. |
2018-05-14 |
| Medigene AG. (5/14/18). "Press Release: Medigene Significantly Expands TCR Alliance with Bluebird Bio in Cancer Immunotherapy". Planegg. |
2018-05-14 |
| Erytech Pharma. (5/14/18). "Press Release: Erytech Strengthens Executive Team with the Appointment of Alex Dusek as VP of Commercial Strategy". Lyon. |
2018-05-14 |
| Polyneuron Pharmaceuticals AG. (5/14/18). "Press Release: Polyneuron Pharmaceuticals Completes CHF3.1 Million Seed Financing". Basel. |
2018-05-14 |
| Agilent Technologies Inc.. (5/14/18). "Press Release: Agilent Completes Acquisition of Genohm". Santa Clara, CA. |
2018-05-14 |
| Affiris AG. (5/14/18). "Press Release: Affiris Announces Encouraging Long-term Data from a Series of First-in-Human Studies Using Affitope PD01A Targeting Oligomeric Alpha-synuclein in Early Parkinsons Disease Patients". Vienna. |
2018-05-14 |
| Bruker Corporation. (5/14/18). "Press Release: Bruker Announces Quarterly Dividend". Billerica, MA. |
2018-05-14 |
| Brainomix Ltd.. (5/11/18). "Press Release: Brainomix Announces CE Mark Certification for New e-CTA Software". Oxford. |
2018-05-11 |
| Arsanis, Inc.. (5/10/18). "Press Release: Arsanis Reports Business Highlights and Financial Results for First Quarter 2018". Waltham, MA & Vienna. |
2018-05-10 |
| Pieris Pharmaceuticals, Inc.. (5/10/18). "Press Release: Pieris Pharmaceuticals Reports First Quarter 2018 Financial Results and Provides Corporate Update". Boston, MA. |
2018-05-10 |
| Memo Therapeutics AG. (5/9/18). "Press Release: Memo Therapeutics AG Closes Series A2 Financing Round of CHF 5 Million to Advance Its Antibody Discovery Programs into Preclinical and Clinical Development". Basel. |
2018-05-09 |
| Novartis AG. (5/9/18). "Press Release: Essential Consultants – Novartis Statement". |
2018-05-09 |
| Oxford Nanopore Technologies Ltd.. (5/9/18). "Press Release: Oxford Nanopore Announces Favourable Outcome in UK and German Patent Litigation against Pacific Biosciences". |
2018-05-09 |
| Bruker Corporation. (5/9/18). "Press Release: 2018 Laukien Prize Winner Announcement". |
2018-05-09 |
| Eurofins Scientific. (5/9/18). "Press Release: Eurofins Expands Its Leadership in Biopharmaceutical Services with the Acquisition of PHAST in Germany". |
2018-05-09 |
| Centogene AG. (5/9/18). "Press Release: Centogene Announces Drug Development Collaboration with Orphazyme in Neuronopathic Gaucher Disease". Rostock. |
2018-05-09 |
| Celonic AG. (5/8/18). "Press Release: Celonic AG Appoints Soenke Brunswieck as Vice President Cell & Gene Therapy". Basel. |
2018-05-08 |
| Cevec Pharmaceuticals GmbH. (5/8/18). "Press Release: Cevec and CSL Limited Sign Exclusive License Agreement for Production of Recombinant C1 Esterase Inhibitor Using Cevec’s Proprietary CAPGo Technology". Cologne & Melbourne. |
2018-05-08 |
| CRISPR Therapeutics AG. (5/8/18). "Press Release: CRISPR Therapeutics Provides Business Update and Reports First Quarter 2018 Financial Results". Zug & Cambridge, MA. |
2018-05-08 |
| CureVac AG. (5/8/18). "Press Release: CureVac Announces New Management Structure. Founder Ingmar Hoerr to Transition to Chairman role; Daniel Menichella to Become CEO". Tübingen. |
2018-05-08 |
| DiaSorin S.p.A.. (5/8/18). "Press Release: The DiaSorin Group Reports Growth in Revenues and Profitability in the First Quarter 2018". Saluggia. |
2018-05-08 |
| Evotec AG. (5/8/18). "Press Release: Evotec and Carna Biosciences Collaborate on INDiGO Platform". Hamburg. |
2018-05-08 |
| InflaRx N.V.. (5/8/18). "Press Release: InflaRx N.V. Announces Closing of Primary and Secondary Offering of Common Shares". Jena. |
2018-05-08 |
| Sygnis AG. (5/8/18). "Press Release: Sygnis Completes Acquisition of TGR Biosciences". Heidelberg & Cambridge. |
2018-05-08 |
| Greiner Bio-One. (5/8/18). "Press Release: Greiner Bio-One Acquires 3D Cell Culture Technology Assets from Nano3D Biosciences, Inc.". |
2018-05-08 |
| Centogene AG. (5/4/18). "Press Release: Centogene Appoints Berndt Modig as New Supervisory Board Member". Rostock. |
2018-05-04 |
| Lonza Group Ltd.. (5/4/18). "Press Release: Lonza Reports Positive Start to 2018 with Businesses Along the Healthcare Continuum as Growth Drivers". Basel. |
2018-05-04 |
| Lonza Group Ltd.. (5/4/18). "Press Release: Lonza to Invest in Portsmouth, NH (USA) Site, including Mid-Scale Biologics". Portsmouth, NH & Basel. |
2018-05-04 |
| Scienion AG. (5/3/18). "Press Release: Revolutionary Milk Analysis Platform Allows for Multiplex Analysis of 100 Antibiotic Residues and Toxins in a Single Test". Berlin & Seraing. |
2018-05-03 |
| SmartDyeLivery GmbH. (5/3/18). "Press Release: Nanoparticles for Life-saving Therapies.
Stiftung für Technologie, Innovation und Forschung Thüringen (STIFT) and Sparkasse Jena-Saale-Holzland count on an innovative therapeutic concept from Jena". Erfurt |
2018-05-03 |
| InflaRx N.V.. (5/3/18). "Press Release: InflaRx N.V. Announces Pricing of Primary and Secondary Offering of Common Shares". Jena. |
2018-05-03 |
| Bruker Corporation. (5/3/18). "Press Release: Bruker Reports First Quarter 2018 Financial Results". Billerica, MA. |
2018-05-03 |
| Affimed N.V.. (5/3/18). "Press Release: Affimed Introduces ROCK Platform for Tailored Immune Cell Engagers". Heidelberg. |
2018-05-03 |
| Qiagen N.V.. (5/2/18). "Press Release: Qiagen Reports Results for First Quarter 2018". Venlo. |
2018-05-02 |
| Agilent Technologies Inc.. (5/2/18). "Press Release: Agilent Technologies to Enhance Lab Informatics with Acquisition of Genohm". Santa Clara, CA. |
2018-05-02 |
| Evotec AG. (5/2/18). "Press Release: Evotec Expands CRISPR-based Technology Offering with Licence from ERS Genomics". Hamburg. |
2018-05-02 |
| MorphoSys AG. (5/2/18). "Press Release: MorphoSys AG Reports First Quarter 2018 Results". Planegg. |
2018-05-02 |
| InflaRx N.V.. (5/2/18). "Press Release: InflaRx N.V. Announces Proposed Primary and Secondary Offerings of Common Shares". Jena. |
2018-05-02 |
| ERS Genomics Ltd.. (5/2/18). "Press Release: ERS Genomics Licenses CRISPR/Cas9 Genome Editing Patents to Evotec". Dublin. |
2018-05-02 |
| Neurimmune AG. (5/1/18). "Press Release: Biogen and Neurimmune Announce Option Exercise for Alzheimer’s Disease Investigational Treatment Aducanumab". Cambridge, MA & Schlieren. |
2018-05-01 |
| Mologic Ltd.. (5/1/18). "Press Release: Mologic Signs Agreements with Medisur and Peripal to Distribute Periplex PoC Diagnostic in Europe". Bedfordshire. |
2018-05-01 |
| AdvanceCor GmbH. (5/18). "Press Release: AdvanceCor GmbH Secures Financing for Proof of Concept Patient Studies with a further Financing Round by an Investor Consortium with Occident Group, Bayernkapital, KfW and MIG AG as Lead investors". Munich & Marti |
2018-05-01 |
| Addex Therapeutics S.A.. (4/30/18). "Press Release: Addex Reports 2017 Full Year Results and Provides Corporate Update". Geneva. |
2018-04-30 |
| Roivant Sciences GmbH. (4/30/18). "Press Release: Datavant Acquires Universal Patient Key and Closes $40M Financing Round". San Francisco, CA. |
2018-04-30 |
| Crescendo Biologics Ltd.. (4/30/18). "Press Release: Crescendo Biologics Ltd. Raises $70 Million (€57 Million) in Series B Financing". Cambridge. |
2018-04-30 |
| NovellusDx Ltd.. (4/30/18). "Press Release: NovellusDx Announced It Has Completed an Equity Financing of $6 Million". Jerusalem. |
2018-04-30 |
| 4D Molecular Therapeutics. (4/30/18). "Press Release: 4DMT and Roche Expand Ophthalmology Partnership to Develop and Commercialize Multiple AAV Gene Therapy Products". Emeryville, CA. |
2018-04-30 |
| Curetis N.V.. (4/30/18). "Press Release: Curetis Announces Change of the Composition of Its Supervisory Board. Dr. Holger Reithinger Resigns as Member of the Supervisory Board". Amsterdam, San Diego, CA & Holzgerlingen. |
2018-04-30 |
| Curetis N.V.. (4/30/18). "Press Release: Curetis Publishes Full-Year 2017 Financial Results and Updated Guidance for 2018". Amsterdam & Holzgerlingen. |
2018-04-30 |
| Bruker Corporation. (4/30/18). "Press Release: Bruker Introduces New NMR Technologies and Research Products". Orlando, FL. |
2018-04-30 |
| Curetis N.V.. (4/27/18). "Press Release: Curetis to Raise EUR 4.1 Million in Equity Offering with Access to Additional USD 10 million in Equity Over 36 Months [Not for United States, Australia, Canada, Japan, or any other jurisdiction where unlawful]". A |
2018-04-27 |
| Sanofi S.A.. (4/27/18). "Press Release: First-quarter 2018 Business EPS up 1.4% at CER". Paris. |
2018-04-27 |
| Polyphor Ltd.. (4/27/18). "Press Release: Polyphor Launches IPO on SIX Swiss Exchange and Sets Price Range [These materials may not be published, distributed or transmitted in the United States, Canada, Australia or Japan. ]". |
2018-04-27 |
| Omeicos Therapeutics GmbH. (4/27/18). "Press Release: Alexander Gebauer Joins Executive Board of Omeicos Therapeutics and Named CEO and Chairman of Omeicos Ophthalmics". Berlin & Boston, MA. |
2018-04-27 |
| Zedira GmbH. (4/26/18). "Press Release: Dr. Falk Pharma and Zedira Announce Start of the Phase 2a Proof of Concept Study of ZED1227 for the Treatment of Celiac Disease". Freiburg & Darmstadt. |
2018-04-26 |
| Neurimmune AG. (4/26/18). "Press Release: Neurimmune Appoints Fabian Buller as Chief Business Officer". Schlieren. |
2018-04-26 |
| Eppendorf AG. (4/26/18). "Press Release: Ready-to-use, Synthetic Surface Cultureware for Human Induced Pluripotent Stem Cells (hiPSCs) Coming to Market". Hamburg. |
2018-04-26 |
| Bruker Corporation. (4/26/18). "Press Release: Bruker Appoints Falko Busse as President of the Bruker BioSpin Group". Billerica, MA. |
2018-04-26 |
| AiCuris Anti-infective Cures GmbH. (4/25/18). "Press Release: Approval of MSD’s Prevymis (letermovir) in Japan Triggers EUR 15 Million Milestone Payment for AiCuris". Wuppertal. |
2018-04-25 |
| Pieris Pharmaceuticals, Inc.. (4/25/18). "Press Release: Pieris Pharmaceuticals Appoints Ann Barbier, M.D., Ph.D., to Its Board of Directors". Boston, MA. |
2018-04-25 |
| Topas Therapeutics GmbH. (4/24/18). "Press Release: Topas Therapeutics and Boehringer Ingelheim Sign Multi-Year Collaboration and Option Agreement". Hamburg. |
2018-04-24 |
| Eppendorf AG. (4/24/18). "Press Release: Fiscal Year 2017 – Eppendorf Continues to Generate Growth above the Market Average". Hamburg. |
2018-04-24 |
| Sanofi S.A.. (4/24/18). "Press Release: Sanofi Head of Global R&D Elias Zerhouni to Retire; Company Names John Reed to Take Over on July 1". Paris. |
2018-04-24 |
| IDT Biologika GmbH. (4/24/18). "Press Release: IDT Biologika Acquires Dr. Felgenträger, Located in the BioPharmaPark Dessau". Dessau-Roslau. |
2018-04-24 |
| Eurofins Scientific. (4/24/18). "Press Release: Eurofins Revenues Grow +23% in Q1 2018 to EUR 839m". |
2018-04-24 |
| Revolution Medicines, Inc.. (4/24/18). "Press Release: Revolution Medicines Raises $56 Million in Series B Financing". Redwood City, CA. |
2018-04-24 |
| Probiodrug AG. (4/23/18). "Press Release: Probiodrug Appoints Dr. Ulrich Dauer as Chief Executive Officer". Halle (Saale). |
2018-04-23 |
| Merck KGaA. (4/23/18). "Press Release: Merck Receives Patent for CRISPR Technology in China". Darmstadt. |
2018-04-23 |
| MorphoSys AG. (4/23/18). "Press Release: MorphoSys Announces Closing of Nasdaq IPO through an ADS Offering and Exercise of the Underwriters' Option to Purchase Additional ADSs, Leading to Total Gross Proceeds of USD 239 million". Planegg. |
2018-04-23 |
| Lead Discovery Center GmbH. (4/23/18). "Press Release: LDC – New Branch for Development of Therapeutic Antibodies in Munich". Dortmund & Munich. |
2018-04-23 |
| Grünenthal GmbH. (4/23/18). "Press Release: Dr. Philip Just Larsen Appointed Chief Scientific Officer (CSO)". Aachen. |
2018-04-23 |
| Mologen AG. (4/20/18). "Press Release: Chief Executive Officer of Mologen AG Will Not Extend Executive Board Mandate Expiring in October 2018 (Ad-hoc News)". Berlin. |
2018-04-20 |
| Qiagen N.V.. (4/20/18). "Press Release: Qiagen Announces FDA Approval of PartoSure". Germantown, MD & Hilden. |
2018-04-20 |
| Bruker Corporation. (4/20/18). "Press Release: Bruker Introduces Bologna Workflow for Rapid and Cost-Effective Clinical Microbiology Diagnosis of Bloodstream Infections with Broad Species Coverage". Madrid. |
2018-04-20 |
| 4SC AG. (4/19/18). "Press Release: Phase II Study of 4SC’s Resminostat in Biliary Tract Cancer in Japan Is Initiated". Planegg-Martinsried. |
2018-04-19 |
| Altona Diagnostics GmbH. (4/19/18). "Press Release: Altona Diagnostics Launches CE-IVD marked AltoStar Molecular Diagnostic Workflow". Hamburg. |
2018-04-19 |
| Qiagen N.V.. (4/19/18). "Press Release: Qiagen Announces European Launch of QIAstat-Dx, a Next Generation Platform for Syndromic Insights". Hilden & Germantown, MD. |
2018-04-19 |
| Merck KGaA. (4/19/18). "Press Release: Merck to Sell Consumer Health to Procter & Gamble". Darmstadt. |
2018-04-19 |
| Merck KGaA. (4/19/18). "Press Release: Merck, University of Cape Town and Medicines for Malaria Venture Join Forces to Feed the Antimalarial Pipeline". Darmstadt. |
2018-04-19 |
| Curetis N.V.. (4/19/18). "Press Release: Curetis Launches CE-IVD Marked Unyvero Urinary Tract Infection (UTI) Cartridge at ECCMID 2018". Amsterdam, San Diego, CA & Holzgerlingen. |
2018-04-19 |
| Idorsia Ltd.. (4/19/18). "Press Release: Idorsia Announces Financial Results for the First Quarter 2018". Allschwil. |
2018-04-19 |
| AiCuris Anti-infective Cures GmbH. (4/18/18). "Press Release: AiCuris and Max Planck Institute of Molecular Physiology Join Forces in the Field of Anti-infectives". Wuppertal & Dortmund. |
2018-04-18 |
| MorphoSys AG. (4/18/18). "Press Release: MorphoSys Announces Pricing of Initial Public Offering of American Depositary Shares (ADSs) on Nasdaq". Planegg. |
2018-04-18 |
| MorphoSys AG. (4/18/18). "Press Release: Ad hoc – MorphoSys Resolves a Capital Increase to Implement the Offering of 8,300,000 American Depositary Shares (ADS) in the United States". Planegg. |
2018-04-18 |
| Ayoxxa Biosystems GmbH. (4/18/18). "Press Release: Ayoxxa Launches Lunaris Human 12-Plex Th17 Kit Expanding Its Portfolio for Fully Scalable Biomarker Analysis". Cologne. |
2018-04-18 |
![[LSG] Life-Sciences-Germany.com - The Life Sciences Web Portal for German-speaking Europe](/images/basics/lsg-life-sciences-germany-portal-logo-2019.png){kind=logo}
1 2 3 ... 9 10 11 ... 96 97 98 
Date![Picture [LSE] Life-Sciences-Europe.com – The Business Web Portal 600x60px](/banner/iito-20181119-600-060-lse-life-sciences-europe-com.jpg)
![Picture [LSUS] Life-Sciences-USA.com – The Business Web Portal 600x60px](/banner/iito-20181119-600-060-lsus-life-sciences-usa-com-beta.jpg)
![Picture [iito] LSE iitoLifeScience Life Sciences Mass Spec 120x120px](/banner/iito-business-intelligence-20111029-120-120-twitter-iitolifescience-germany-europe-mass-spec.jpg)
![Picture [LSE] Life-Sciences-Europe.com – The Business Web Portal 120x600px](/banner/iito-20150801-120-600-lse-life-sciences-europe-com.jpg)
